About Bloom Diagnostics
Bloom Diagnostics is a company based in Zurich (Switzerland) founded in 2018 by Tom Kupper. Bloom Diagnostics has raised $17.3 million across 2 funding rounds from investors including Speedinvest, Thomas Pfisterer and Walter Ventures. Bloom Diagnostics offers products and services including Ferritin Test, Thyroid Test, Inflammation Test, Ovarian Reserve Test, and Kidney Test. Bloom Diagnostics operates in a competitive market with competitors including Cue Health, Profusa, Level Zero Health, Valencell and InnaMed, among others.
- Headquarter Zurich, Switzerland
- Founders Tom Kupper
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.3 M (USD)
in 2 rounds
-
Latest Funding Round
$11.7 M (USD), Series B
Aug 25, 2020
-
Investors
Speedinvest
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bloom Diagnostics
Bloom Diagnostics offers a comprehensive portfolio of products and services, including Ferritin Test, Thyroid Test, Inflammation Test, Ovarian Reserve Test, and Kidney Test.
Measures iron stores to detect deficiency or overload.
Assesses thyroid function for hypothyroidism screening.
Detects C-reactive protein levels for inflammation.
Evaluates Anti-Müllerian hormone for fertility assessment.
Measures cystatin C for kidney function evaluation.
Analyzes test strips and sends results via app.
People of Bloom Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Bloom Diagnostics
Bloom Diagnostics has successfully raised a total of $17.3M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.7 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bloom Diagnostics
Bloom Diagnostics has secured backing from 3 investors, including angel and venture fund investors. Prominent investors backing the company include Speedinvest, Thomas Pfisterer and Walter Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital and startup acceleration are provided.
|
Locked | Locked | Locked | |
|
Impact-driven early-stage B2B software companies are funded by Walter Ventures.
|
Locked | Locked | Locked | |
|
TP
Thomas Pfisterer |
-
|
Locked | Locked | Locked |
Investor details for Bloom Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bloom Diagnostics
Investment portfolio details for Bloom Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bloom Diagnostics
Detailed financials for Bloom Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bloom Diagnostics Comparisons
Peer comparison for Bloom Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bloom Diagnostics
Bloom Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cue Health, Profusa, Level Zero Health, Valencell and InnaMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides comprehensive health monitoring systems for diagnosing diseases like influenza.
|
|
| Locked | Locked | Locked |
Biochemical sensors are developed for real-time chronic disease monitoring.
|
|
| Locked | Locked | Locked |
Developer of biosensor technology for continuous hormone monitoring
|
|
| Locked | Locked | Locked |
AI-based medical sensors for monitoring body vitals are developed.
|
|
| Locked | Locked | Locked |
Delivers wearable devices for comprehensive blood glucose level monitoring.
|
|
| Locked | Locked | Locked |
Offers at-home medical devices for inflammation monitoring via blood tests and data analysis.
|
Detailed competitors of Bloom Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bloom Diagnostics
Complete news archive for Bloom Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bloom Diagnostics
Bloom Diagnostics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Bloom Diagnostics is headquartered in Zurich, Switzerland.
Bloom Diagnostics is a funded company, having raised a total of $17.3M across 2 funding rounds to date.
Bloom Diagnostics was founded in 2018 in Zurich, Switzerland, focusing on the health diagnostics sector. Medical self-assessment devices and accompanying software are produced to measure blood markers and generate personalized health reports. Data is captured through the devices, recorded via a mobile app, and processed in real time to support user health monitoring. Operations emphasize individual self-analysis tools for accessible health insights.
Bloom Diagnostics's top competitors include Profusa, Valencell and Level Zero Health.
Bloom Diagnostics offers Ferritin Test, Thyroid Test, Inflammation Test, Ovarian Reserve Test, and 2 more products and services.
Bloom Diagnostics has 3 investors. Key investors include Speedinvest, Thomas Pfisterer, and Walter Ventures.